Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
about
Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptorsEpstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptorsCharacterization of ABF-1, a novel basic helix-loop-helix transcription factor expressed in activated B lymphocytes.The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIEEpstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2Epstein-Barr virus infection induces expression in B lymphocytes of a novel gene encoding an evolutionarily conserved 55-kilodalton actin-bundling proteinEpstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1Protein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins.B cell activation and the establishment of Epstein-Barr virus latencyTranscriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and Rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15).Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.The Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/Pax5Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element.Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus.Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virusThe Epstein-Barr virus and its association with human cancers.A somatic knockout of CBF1 in a human B-cell line reveals that induction of CD21 and CCR7 by EBNA-2 is strictly CBF1 dependent and that downregulation of immunoglobulin M is partially CBF1 independent.Epstein-Barr virus (EBV)-associated epithelial and non-epithelial lesions of the oral cavity.Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cellsBHRF1 of Epstein-Barr virus, which is homologous to human proto-oncogene bcl2, is not essential for transformation of B cells or for virus replication in vitro.Contrasts in codon usage of latent versus productive genes of Epstein-Barr virus: data and hypotheses.The expression and function of Epstein-Barr virus encoded latent genesThe MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia.Immortalization of human primary B lymphocytes in vitro with DNA.Molecular virology of Epstein-Barr virus.Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytesBinding site for IgE of the human lymphocyte low-affinity Fc epsilon receptor (Fc epsilon RII/CD23) is confined to the domain homologous with animal lectins.Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformationThe human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements.Epstein-barr virus-induced changes in B-lymphocyte gene expression.The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoterMolecular structure of the gene and the 5'-flanking region of the human lymphocyte immunoglobulin E receptor.Correlation of gene expression and genome mutation in single B-cells.Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming.Cellular target genes of Epstein-Barr virus nuclear antigen 2.Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells.Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan.The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.
P2860
Q22010043-E45A1338-DDC6-4C8E-B574-9BF9BCFAED00Q24314660-C28FD462-AE3F-44B3-83DC-61A72E13E222Q24315641-8957E390-CFFF-4FF3-B8A2-1AD3EDFAE3D6Q24329182-2A8D5743-4455-422B-963F-DD0C63DC4CABQ24540313-8F625772-1D9A-4B0A-B3ED-13854FAEA306Q24564767-7FD18E16-EFD7-4B60-8FF5-7BFE7D5B06FEQ24645568-B220BC21-6AE0-4D14-B74F-CD5CDC2FB224Q24681418-C2A317A4-3906-44C8-9B93-DC99FF739B14Q28114910-653CC0CE-F158-4C25-A97A-85D61E722D78Q28281625-4C4123A5-D814-4274-8A5B-8FC9A9851EEBQ33639938-E0EB083D-DBDD-4182-8FE6-B9580AFCC37CQ33786088-216A55D7-59C6-4F59-A9F5-00C2EDF49FF9Q33787243-B7642122-F50A-4CB2-B0D8-AC15369EE209Q33797347-951AD604-10F0-4AF9-BFFE-71AC18815047Q33810690-7E5C8F08-6A7A-4A61-823B-287035DAF87FQ33842309-BE5C6823-17B8-4B9B-AC6E-2468F9CA9C5AQ33865166-C7227048-660A-4665-B0BA-FEFD1EF8DE17Q33882153-C2C82242-B2BB-47B1-9611-925123772381Q33884014-F3E4F1DE-E42B-4499-9195-AFAA384E7B26Q33884691-C5EDB040-BC0F-4BC8-9EA7-C6E278C1052CQ33929593-1F61A29D-3832-4F63-BE40-923D28196374Q33930251-2488DCA4-DE17-420E-B119-97DD9ADF0D4EQ33930793-476569B3-A995-461C-A0CF-CF48C794F71FQ34089485-584AB267-9B8B-45E9-9321-27F85AB61427Q34097631-C53A0244-4A11-4BBE-9288-2E6C60933534Q34160976-5B277B7D-9F68-43C3-BBDF-07825539115EQ34225554-662CA922-8D68-4A1C-928E-CC6302736005Q34299744-1B1731D8-481B-4404-A9C4-B03A155BB520Q34304202-092013F4-5DC3-438A-9823-CE6B071781E3Q34324039-8E68492F-D699-486E-A59F-ACB8CEB4C411Q34327455-9410F6F8-A119-4397-AF30-83E7F3EF932FQ34347958-31E5176E-0D69-4C25-B8A8-75D12E24F17EQ34355226-BD4D1E68-81FD-4A3C-A37E-25074EAB16B4Q34708009-BD4988E6-1F78-4DF1-8269-208E3FC23D54Q34807778-453B01D3-7160-42BC-9D66-3FDF33AB7D44Q34998243-3B9EB620-DE97-499E-998B-05B77B03C697Q35101342-9568D6DC-5524-4706-9883-0F67B15A9A4BQ35540042-D736BBD0-E2AC-4CF6-8E87-6A8A39D15B3AQ35586187-8E4CCA88-9B35-45D3-84F0-04EB52BDA323Q35648541-430E8EBE-D230-4130-9F3A-CAC13A2EB8BB
P2860
Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
description
1987 nî lūn-bûn
@nan
1987 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Epstein-Barr virus nuclear ant ...... -cell activation antigen CD23.
@ast
Epstein-Barr virus nuclear ant ...... -cell activation antigen CD23.
@en
Epstein-Barr virus nuclear ant ...... -cell activation antigen CD23.
@nl
type
label
Epstein-Barr virus nuclear ant ...... -cell activation antigen CD23.
@ast
Epstein-Barr virus nuclear ant ...... -cell activation antigen CD23.
@en
Epstein-Barr virus nuclear ant ...... -cell activation antigen CD23.
@nl
prefLabel
Epstein-Barr virus nuclear ant ...... -cell activation antigen CD23.
@ast
Epstein-Barr virus nuclear ant ...... -cell activation antigen CD23.
@en
Epstein-Barr virus nuclear ant ...... -cell activation antigen CD23.
@nl
P2093
P2860
P356
P1476
Epstein-Barr virus nuclear ant ...... -cell activation antigen CD23.
@en
P2093
A B Rickinson
C D Gregory
H Kikutani
M Birkenbach
T Kishimoto
P2860
P304
P356
10.1073/PNAS.84.10.3452
P407
P577
1987-05-01T00:00:00Z